State Street Corp Nex Immune, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.61 - $4.68 $307,669 - $894,343	-191,099 Reduced 89.29%	22,919 $37,000
Q1 2022 May 16, 2022	BUY	$1.79 - $4.65 $33,526 - $87,094	18,730 Added 9.59%	214,018 $901,000
Q4 2021 Feb 14, 2022	BUY	$4.11 - $15.13 $135,790 - $499,880	33,039 Added 20.36%	195,288 $900,000
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $686,641 - $1.12 Million	66,535 Added 69.51%	162,249 $2.46 Million
Q2 2021 Aug 16, 2021	BUY	$14.98 - $23.89 $707,954 - $1.13 Million	47,260 Added 97.54%	95,714 $1.56 Million
Q1 2021 May 17, 2021	BUY	$17.95 - $25.91 $869,749 - $1.26 Million	48,454 New	48,454 $925,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $7.25M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.